Literature DB >> 25587656

Treatment of recurrent and severe Clostridium difficile infection.

J J Keller1, E J Kuijper.   

Abstract

Clostridium difficile infection (CDI) is a serious complication of hospitalization and antibiotic use with a high mortality and very high costs. Despite appropriate treatment, a subset of patients develop chronic recurrent CDI. Some other patients develop severe and life-threatening colitis. The risk factors, pathogenesis, and treatment of recurrent CDI and severe CDI are discussed in this review. In particular, fecal microbiota transplantation (FMT) as a treatment strategy is outlined and a treatment algorithm incorporating FMT is described.

Entities:  

Keywords:  donor feces; fidaxomicin; microbiota; transplantation

Mesh:

Substances:

Year:  2015        PMID: 25587656     DOI: 10.1146/annurev-med-070813-114317

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  10 in total

Review 1.  Clostridium difficile Infection: An Epidemiology Update.

Authors:  Ana C De Roo; Scott E Regenbogen
Journal:  Clin Colon Rectal Surg       Date:  2020-02-25

2.  Comparison of Whole-Genome Sequence-Based Methods and PCR Ribotyping for Subtyping of Clostridioides difficile.

Authors:  A Baktash; J Corver; C Harmanus; W K Smits; W Fawley; M H Wilcox; N Kumar; D W Eyre; A Indra; A Mellmann; E J Kuijper
Journal:  J Clin Microbiol       Date:  2021-12-15       Impact factor: 11.677

Review 3.  Gut Microbiota and Colonization Resistance against Bacterial Enteric Infection.

Authors:  Q R Ducarmon; R D Zwittink; B V H Hornung; W van Schaik; V B Young; E J Kuijper
Journal:  Microbiol Mol Biol Rev       Date:  2019-06-05       Impact factor: 11.056

Review 4.  Influence of Microbiota on Intestinal Immune System in Ulcerative Colitis and Its Intervention.

Authors:  Sai-Long Zhang; Shu-Na Wang; Chao-Yu Miao
Journal:  Front Immunol       Date:  2017-11-28       Impact factor: 7.561

5.  Management of Recurrent Clostridium difficile Infection During Intensive Chemotherapy and Stem Cell Transplantation for Leukemia: Case with Literature Review.

Authors:  Umar Zahid; Fnu Sagar; Mayar Al Mohajer; Aneela Majeed
Journal:  Cureus       Date:  2018-04-02

Review 6.  Mechanistic Insights in the Success of Fecal Microbiota Transplants for the Treatment of Clostridium difficile Infections.

Authors:  Amoe Baktash; Elisabeth M Terveer; Romy D Zwittink; Bastian V H Hornung; Jeroen Corver; Ed J Kuijper; Wiep Klaas Smits
Journal:  Front Microbiol       Date:  2018-06-12       Impact factor: 5.640

7.  Early Results of Fecal Microbial Transplantation Protocol Implementation at a Community-based University Hospital.

Authors:  Rodrigo Duarte-Chavez; Thomas R Wojda; Thomas B Zanders; Berhanu Geme; Gloria Fioravanti; Stanislaw P Stawicki
Journal:  J Glob Infect Dis       Date:  2018 Apr-Jun

Review 8.  Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy.

Authors:  Lin Shui; Xi Yang; Jian Li; Cheng Yi; Qin Sun; Hong Zhu
Journal:  Front Immunol       Date:  2020-01-17       Impact factor: 7.561

Review 9.  Host Immune Responses to Clostridioides difficile: Toxins and Beyond.

Authors:  Britt Nibbering; Dale N Gerding; Ed J Kuijper; Romy D Zwittink; Wiep Klaas Smits
Journal:  Front Microbiol       Date:  2021-12-21       Impact factor: 5.640

10.  How to prepare stool banks for an appropriate response to the ongoing COVID-19 pandemic: Experiences in the Netherlands and a retrospective comparative cohort study for faecal microbiota transplantation.

Authors:  Bas Groenewegen; Emilie van Lingen; Rogier E Ooijevaar; Els Wessels; Mariet C W Feltkamp; Eline Boeije-Koppenol; Hein W Verspaget; Ed J Kuijper; Joffrey van Prehn; Josbert J Keller; Elisabeth M Terveer
Journal:  PLoS One       Date:  2022-03-17       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.